MB, Levis & Associates’s Lemonade LMND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.9K Hold
60
﹤0.01% 209
2026
Q1
$3.76K Hold
60
﹤0.01% 193
2025
Q4
$4.27K Hold
60
﹤0.01% 191
2025
Q3
$3.21K Hold
60
﹤0.01% 199
2025
Q2
$2.63K Hold
60
﹤0.01% 238
2025
Q1
$1.89K Hold
60
﹤0.01% 251
2024
Q4
$2.2K Hold
60
﹤0.01% 258
2024
Q3
$989 Hold
60
﹤0.01% 271
2024
Q2
$990 Hold
60
﹤0.01% 265
2024
Q1
$985 Hold
60
﹤0.01% 260
2023
Q4
$968 Hold
60
﹤0.01% 257
2023
Q3
$697 Hold
60
﹤0.01% 263
2023
Q2
$1.01K Hold
60
﹤0.01% 258
2023
Q1
$856 Hold
60
﹤0.01% 260
2022
Q4
$821 Buy
+60
New +$1.19K ﹤0.01% 239

Other funds holding LMND

MB, Levis & Associates's LMND Position: Q2 2026 in Review

MB, Levis & Associates held its Lemonade (LMND) position steady in Q2 2026 at 60 shares worth $3.9K. The position accounts for ﹤0.01% of the portfolio, ranked #209.

MB, Levis & Associates first reported a position in LMND in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.27K in Q4 2025. 336 funds tracked by Wall St. Rank hold LMND as of Q2 2026.

  • MB, Levis & Associates held 60 shares of Lemonade worth $3.9K as of Q2 2026.
  • MB, Levis & Associates left its Lemonade share count unchanged in Q2 2026.
  • Lemonade made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #209 holding.
  • MB, Levis & Associates first reported a position in Lemonade in Q4 2022 and has held it in 15 quarters since.
  • MB, Levis & Associates's Lemonade position peaked at $4.27K in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Lemonade as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.